Assenagon Asset Management
CYTK icon

Assenagon Asset Management’s Cytokinetics CYTK Stock Holding History

Assenagon Asset Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-554,658
Closed -$46.3M – 1391
2023
Q4 		$46.3M Buy
+554,658
New +$20.1M 0.12% 143
2023
Q3 		– Sell
-101,327
Closed -$3.31M – 1399
2023
Q2 		$3.31M Buy
101,327
+66,709
+193% +$2.47M 0.01% 597
2023
Q1 		$1.22M Buy
+34,618
New +$1.41M ﹤0.01% 982
2022
Q3 		– Sell
-589,274
Closed -$23.2M – 1382
2022
Q2 		$23.2M Sell
589,274
-900,678
-60% -$36.3M 0.09% 206
2022
Q1 		$54.8M Buy
1,489,952
+1,445,969
+3,288% +$51.4M 0.15% 123
2021
Q4 		$2M Sell
43,983
-41,134
-48% -$1.59M 0.01% 821
2021
Q3 		$3.04M Sell
85,117
-113,516
-57% -$3.34M 0.01% 572
2021
Q2 		$3.93M Sell
198,633
-32,399
-14% -$761K 0.01% 536
2021
Q1 		$5.37M Buy
+231,032
New +$4.93M 0.02% 489
2020
Q4 		– Sell
-137,453
Closed -$2.98M – 1070
2020
Q3 		$2.98M Buy
+137,453
New +$3.22M 0.02% 487
2020
Q2 		– Sell
-121,510
Closed -$1.43M – 1137
2020
Q1 		$1.43M Buy
+121,510
New +$1.55M 0.01% 434
2019
Q4 		– Sell
-60,583
Closed -$689K – 801
2019
Q3 		$689K Buy
+60,583
New +$760K ﹤0.01% 641

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Assenagon Asset Management's CYTK Position: Q1 2024 in Review

Assenagon Asset Management sold out of Cytokinetics (CYTK) in Q1 2024, closing a stake of 554,658 shares — an estimated $46.3M sold.

Assenagon Asset Management first reported a position in CYTK in Q3 2019 and held it in 12 quarters. The position peaked at $54.8M in Q1 2022. 390 funds tracked by Wall St. Rank hold CYTK as of Q1 2024.

  • Assenagon Asset Management reported no remaining Cytokinetics position as of Q1 2024 after selling out during the quarter.
  • Assenagon Asset Management sold 554,658 Cytokinetics shares in Q1 2024, an estimated $46.3M.
  • Assenagon Asset Management first reported a position in Cytokinetics in Q3 2019 and held it in 12 quarters.
  • Assenagon Asset Management's Cytokinetics position peaked at $54.8M in Q1 2022.
  • 390 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2024.

Based on Assenagon Asset Management's 13F filing for Q1 2024, filed 24 Apr 2024.